Kyowa Hakko Kirin Of Japan To Acquire ProStrakan Of U.K.
Japan's Kyowa Hakko Kirin said it plans to buy U.K.-based ProStrakan Group and its cancer drugs for $472 million
Japan's Kyowa Hakko Kirin said it plans to buy U.K.-based ProStrakan Group and its cancer drugs for $472 million